BLCO: Bausch + Lomb Corporation
Performance
BLCO +34.79%
Watchlist
Select an item
Summary
BLCO at a glance
BLCO returned +34.79% over the past year. Its worst drop in that year was -20.11%, smaller than 79% of stocks on Redstone, and its Sharpe ratio of 0.96 beats 73% of stocks on Redstone. It pays no dividends.
Current Drawdown
0.00%
Rolling Volatility
65.25%
Actions
Metrics
Risk Indicators
Alpha22.04%
Beta0.97x
Sharpe0.96
Sortino1.57
Omega1.19
Calmar1.73
Martin3.17
Profile
About BLCO
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals.
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Market cap
- $7.5B
- Listed
- May 2022
- Employees
- 13,000
- Headquarters
- Vaughan, A6
- Website
- bausch.com
Comparisons